Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of the Endocannabinoids During the Analgesia Caused by Hypnosis and Meditation

NCT03407937 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT03407937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03407937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of the Endocannabinoids During the Analgesia Caused by Hypnosis and Meditation
Lead sponsor
Université de Sherbrooke
Phase
Not applicable
Overall status
Completed
Start date
November 14, 2017
Completion date
September 1, 2018
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia, endocannabinoids, hypnosis